The present invention relates to a method for alleviating pain in a subject in need thereof, which comprises administering an effective amount of piscidin (PCD) peptide and a pharmaceutically acceptable carrier to the subject.

Structurally stabilized, e.g., stapled, peptides with the ability to translocate through microbial cell membranes to the interior of microbial cells and exert a biological activity there are provided, as are methods of designing, making and using such peptides.

The present invention relates to peptides for use in the treatment of metabolic disorders. In particular, the present invention relates to peptides for use in the treatment of diabetes. According to the present invention, there is provided a peptide for use in the treatment of a metabolic disorder: wherein the peptide is a piscine-derived PYYor fragment or analogue thereof.

The present invention relates generally to methods and compositions useful for treating skin on a subject. In some embodiments, methods and compositions disclosed herein comprise topical or oral administration of nutraceutical and/or topical composition, wherein the composition comprises at least two of puerarin, collagen, and hyaluronic acid.

The present invention relates generally to methods and compositions useful for treating skin on a subject. In some embodiments, methods and compositions disclosed herein comprise topical or oral administration of nutraceutical and/or topical composition, wherein the composition comprises at least two of puerarin, collagen, and hyaluronic acid.

The present disclosure provides compositions and methods for increasing type I, III, and V collagen in an animal can comprise administering a food composition to the animal, wherein the food composition comprises from about 30% to about 65% protein, from about 0.1% to about 30% starch, and from about 10% to about 40% fat. Additionally, the food composition can have a protein to starch ratio of at least 2:1.